RecruitingNCT03604133
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
Sponsor
QuesGen Systems Inc
Enrollment
500 participants
Start Date
Aug 24, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.
Eligibility
Inclusion Criteria1
- Physician recommendation to receive the implant in an Ambulatory Surgical Center (ASC)
Exclusion Criteria1
- N/A
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03604133
Related Trials
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180320 locations
DiamondTemp Global Registry
NCT0473501621 locations
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
NCT007335904 locations
Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia
NCT062507123 locations
Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery
NCT070969731 location